For proposed rights issue
Sun Pharma Advanced Research Company announced that it has received the FIPB approval for an aggregate amount of Rs 250 crore in the proposed rights issue.Powered by Capital Market - Live News
Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
For proposed rights issue
Sun Pharma Advanced Research Company announced that it has received the FIPB approval for an aggregate amount of Rs 250 crore in the proposed rights issue.Powered by Capital Market - Live News
First Published: Oct 29 2015 | 5:37 PM IST